I
Iterum Therapeutics plc D
D
ITRM
0.93010
USD
-0.05
(-5.07%)
مغلق
حجم التداول
11,091
الربح لكل سهم
-0
العائد الربحي
-
P/E
-1
حجم السوق
37,204,000
الأخبار المقالات
العنوان: Iterum Therapeutics plc
القطاع: Healthcare
الصناعة: Biotechnology
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.